AHL Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-29,001
Closed -$704K 1211
2017
Q1
$704K Sell
29,001
-20,264
-41% -$547K 0.02% 887
2016
Q4
$1.33M Buy
49,265
+30,427
+162% +$751K 0.04% 605
2016
Q3
$421K Sell
18,838
-4,647
-20% -$93.3K 0.02% 883
2016
Q2
$500K Buy
23,485
+1,487
+7% +$28K 0.03% 606
2016
Q1
$388K Buy
+21,998
New +$328K 0.02% 617

Other funds holding PTEN

AHL Partners's PTEN Position: Q2 2017 in Review

AHL Partners sold out of Patterson-UTI (PTEN) in Q2 2017, closing a stake of 29,001 shares — an estimated $704K sold.

AHL Partners first reported a position in PTEN in Q1 2016 and held it in 5 quarters. The position peaked at $1.33M in Q4 2016. 310 funds tracked by Wall St. Rank hold PTEN as of Q2 2017.

  • AHL Partners reported no remaining Patterson-UTI position as of Q2 2017 after selling out during the quarter.
  • AHL Partners sold 29,001 Patterson-UTI shares in Q2 2017, an estimated $704K.
  • AHL Partners first reported a position in Patterson-UTI in Q1 2016 and held it in 5 quarters.
  • AHL Partners's Patterson-UTI position peaked at $1.33M in Q4 2016.
  • 310 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2017.

Based on AHL Partners's 13F filing for Q2 2017, filed 14 Aug 2017.